US Stock MarketDetailed Quotes

RNAC Cartesian Therapeutics

Watchlist
  • 13.370
  • +0.500+3.89%
Close Aug 9 16:00 ET
  • 13.370
  • 0.0000.00%
Post 16:00 ET
285.88MMarket Cap-283P/E (TTM)

Cartesian Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cartesian Therapeutics Earnings Date

Currency: USD

Period

Q2 FY2024 Earnings

--

Revenue(YoY)

33.45M

+537.17%
EPS(YoY)

0.54

+124.22%
Analyst Rating

Strong Buy

Aug 9, 2024

Cartesian Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 2.636M--
--2024/Q3-- / 2.579M--
--2024/Q233.445M / 5.506M--
--2024/Q15.840M / 0.000--
--2023/Q4-- / 2.500M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 2.636M--
--2024/Q3-- / 2.579M--
--2024/Q233.445M / 5.506M--
--2024/Q15.840M / 0.000--
--2023/Q4-- / 2.500M--

Unlock Free Earnings Estimates

Cartesian Therapeutics Earnings Reports

  • Cartesian Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 07:09 ET

  • Cartesian Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 8 07:08 ET

  • Cartesian Therapeutics | 10-K: FY2023 Annual Report

    Mar 7 07:14 ET

  • Cartesian Therapeutics: Q3 2023 Earnings Report

    Nov 13, 2023 16:31 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 9, 2024

    Strong Buy

    • Buy

      85.71%

    • Hold

      14.29%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg